Beyfortus 50 & 100 Mg 50 mg & 100 mg Solution for injection
Clinical Summary
Quick overview from the medicine insert
Indication
Prevention of respiratory syncytial virus (RSV) infection in infants and young children at high risk of RSV disease.
Dosage (summary)
Single dose of 50 mg or 100 mg administered as an intramuscular injection, depending on the patient's weight and age.
Onset of Action / Duration
Protection begins within a few days of administration and lasts for the RSV season.
Special Populations
- Infants under 2 years of age
- Children with chronic lung disease
- Children with congenital heart disease
Pregnancy & Breastfeeding
Limited data available; use only if the potential benefit justifies the potential risk to the fetus. Caution is advised during lactation.
Key Drug Interactions
- No significant drug interactions have been identified; however, caution is advised when used with immunosuppressive agents.
Contraindications
- Hypersensitivity to nirsevimab or any of its components.
- Severe allergic reactions to monoclonal antibodies.
Common side effects
- Injection site reactions (pain, redness, swelling)
- Fever
- Rash
- Fatigue
Counselling Points
- Inform caregivers about the purpose of the injection and the importance of RSV prevention.
- Advise on potential side effects and when to seek medical attention.
- Ensure that the injection is administered by a healthcare professional.
Serious warnings
- Monitor for signs of allergic reactions post-injection.
- Use with caution in patients with a history of severe allergic reactions.
Important Disclaimer
The Beyfortus 50 & 100 Mg 50 mg & 100 mg Solution for injection professional information leaflet below is the property of Sanofi-Aventis South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
